Kenneth Smith
Hospice and Palliative Medicine · Metairie, LANPI 1356310650
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 234 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,110 and has fallen 86.1% since, to $154 in 2025. Among hospice and palliative medicine clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 234 payments — averaging $18.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$942
- GSK$904
- Boehringer Ingelheim$450
- Sunovion Pharmaceuticals Inc.$317
- Regeneron Healthcare Solutions, Inc.$298
- Actelion Pharmaceuticals US, Inc.$164
- plus $1K from 21 others
What the payments were for
- Food & beverage$4,34099%
- Education$391%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 38 | $942 |
| GSK | 65 | $904 |
| Boehringer Ingelheim | 28 | $450 |
| Sunovion Pharmaceuticals Inc. | 21 | $317 |
| Regeneron Healthcare Solutions, Inc. | 15 | $298 |
| Actelion Pharmaceuticals US, Inc. | 7 | $164 |
| Grifols USA, LLC | 7 | $152 |
| Mylan Specialty L.p. | 7 | $124 |
| Novartis | 2 | $119 |
| United Therapeutics Corporation | 5 | $110 |
| Bayer | 6 | $110 |
| Amgen | 1 | $97 |
| Genentech USA, Inc. | 4 | $75 |
| Scpharmaceuticals Inc. | 4 | $70 |
| Sanofi | 3 | $60 |
| Baxter Healthcare | 3 | $58 |
| Johnson & Johnson(2 entities) | 2 | $56 |
| CSL Behring | 2 | $39 |
| Electromed, Inc. | 2 | $37 |
| Inogen, Inc. | 2 | $36 |
| E.r. Squibb & Sons, L.L.C. | 3 | $35 |
| Philips North America LLC | 2 | $30 |
| Inari Medical, Inc. | 1 | $24 |
| Gilead | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Insmed, Inc. | 1 | $15 |
| Circassia Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI AEROSPHERE$126
- BREZTRI$125
- Fabhalta$103
How this compares
$4,378 in reported general payments places this provider in the 95th percentile of 21 hospice and palliative medicine providers in Louisiana.
See all hospice and palliative medicine providers in Louisiana →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $11,841 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 15 | $1,866 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 22 | $920 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $904 | $11,84119 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 21 hospice and palliative medicine providers in Louisiana.
Other hospice and palliative medicine in Metairie
- Trenice AdamsMetairie$560
- Ricardo FebryMetairie$206
- Ty HargroderEunice$4K
- Farah AliCovington$676
- Michelle BergeronLafayette$585
- Kathryn JonesNew Orleans$440
- Ryan BasquezBaton Rouge$271
- Susan NelsonNew Orleans$237
- Katelyn BriggsNew Orleans$215
- Amardeep SinghTerrytown$164
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.